Literature DB >> 14660878

Blood coagulation factor VIII: An overview.

G M Bhopale1, R K Nanda.   

Abstract

Factor VIII (FVIII) functions as a co-factor in the blood coagulation cascade for the proteolytic activation of factor X by factor IXa. Deficiency of FVIII causes hemophilia A, the most commonly inherited bleeding disorder. This review highlights current knowledge on selected aspects of FVIII in which both the scientist and the clinician should be interested.

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 14660878     DOI： 10.1007/bf02708439

Source DB:  PubMed          Journal:  J Biosci        ISSN： 0250-5991            Impact factor:   1.826


  53 in total

1.  The international registry of immune tolerance: 1994 update.

Authors:  A Ghirardini; M Puopolo; F Chiarotti; G Mariani
Journal:  Vox Sang       Date:  1996       Impact factor: 2.144

2.  Factor VIII gene inversions in severe hemophilia A: results of an international consortium study.

Authors:  S E Antonarakis; J P Rossiter; M Young; J Horst; P de Moerloose; S S Sommer; R P Ketterling; H H Kazazian; C Négrier; C Vinciguerra; J Gitschier; M Goossens; E Girodon; N Ghanem; F Plassa; J M Lavergne; M Vidaud; J M Costa; Y Laurian; S W Lin; S R Lin; M C Shen; D Lillicrap; S A Taylor; S Windsor; S V Valleix; K Nafa; Y Sultan; M Delpech; C L Vnencak-Jones; J A Phillips; R C Ljung; E Koumbarelis; A Gialeraki; T Mandalaki; P V Jenkins; P W Collins; K J Pasi; A Goodeve; I Peake; F E Preston; M Schwartz; E Scheibel; J Ingerslev; D N Cooper; D S Millar; V V Kakkar; F Giannelli; J A Naylor; E F Tizzano; M Baiget; M Domenech; C Altisent; J Tusell; M Beneyto; J I Lorenzo; C Gaucher; C Mazurier; K Peerlinck; G Matthijs; J J Cassiman; J Vermylen; P G Mori; M Acquila; D Caprino; H Inaba
Journal:  Blood       Date:  1995-09-15       Impact factor: 22.113

3.  Identification and functional importance of tyrosine sulfate residues within recombinant factor VIII.

Authors:  D D Pittman; J H Wang; R J Kaufman
Journal:  Biochemistry       Date:  1992-04-07       Impact factor: 3.162

Review 4.  Factor VIII structure and function.

Authors:  P A Foster; T S Zimmerman
Journal:  Blood Rev       Date:  1989-09       Impact factor: 8.250

5.  Differential interaction of coagulation factor VIII and factor V with protein chaperones calnexin and calreticulin.

Authors:  S W Pipe; J A Morris; J Shah; R J Kaufman
Journal:  J Biol Chem       Date:  1998-04-03       Impact factor: 5.157

6.  Immune tolerance in hemophilia-principal results from the International Registry. Report of the factor VIII and IX Subcommittee.

Authors:  G Mariani; A Ghirardini; R Bellocco
Journal:  Thromb Haemost       Date:  1994-07       Impact factor: 5.249

7.  Clinical course of factor VIII inhibitors developed after exposure to a pasteurised Dutch concentrate compared to classic inhibitors in hemophilia A.

Authors:  E P Mauser-Bunschoten; F R Rosendaal; H K Nieuwenhuis; G Roosendaal; E Briët; H M van den Berg
Journal:  Thromb Haemost       Date:  1994-06       Impact factor: 5.249

Review 8.  Immune tolerance: a synopsis of the international experience.

Authors:  D M Di Michele
Journal:  Haemophilia       Date:  1998-07       Impact factor: 4.287

9.  A higher than expected incidence of factor VIII inhibitors in multitransfused haemophilia A patients treated with an intermediate purity pasteurized factor VIII concentrate.

Authors:  K Peerlinck; J Arnout; J G Gilles; J M Saint-Remy; J Vermylen
Journal:  Thromb Haemost       Date:  1993-02-01       Impact factor: 5.249

10.  A role for the C2 domain of factor VIII in binding to von Willebrand factor.

Authors:  E L Saenko; M Shima; K J Rajalakshmi; D Scandella
Journal:  J Biol Chem       Date:  1994-04-15       Impact factor: 5.157
View more
  13 in total

1.  Antihemophilic factor [recombinant], formulated with sucrose.

Authors: 
Journal:  P T       Date:  2010-09

2.  Coagulation factor VIII levels are associated with long-term survival - interactions with gender in a large hospital-based cohort.

Authors:  Florian M Kovar; Claudia L Marsik; Christian Joukhadar; Thomas Perkmann; Helmuth Haslacher; Thomas Schickbauer; Paul A Kyrle; Oswald F Wagner; Georg Endler
Journal:  Wien Klin Wochenschr       Date:  2010-06-25       Impact factor: 1.704

3.  High coagulation factor VIII and von Willebrand factor in patients with lymphoma and leukemia.

Authors:  Martin Mohren; Kathleen Jentsch-Ullrich; Michael Koenigsmann; Siegfried Kropf; Enrico Schalk; Gerd Lutze
Journal:  Int J Hematol       Date:  2015-11-26       Impact factor: 2.490

4.  Covalent inactivation of factor VIII antibodies from hemophilia A patients by an electrophilic FVIII Analog.

Authors:  Stephanie Planque; Miguel A Escobar; Keri C Smith; Hiroaki Taguchi; Yasuhiro Nishiyama; Elizabeth Donnachie; Kathleen P Pratt; Sudhir Paul
Journal:  J Biol Chem       Date:  2008-03-11       Impact factor: 5.157

5.  Recombinant Factor VIII Measurement in a Hemophilia A Patient Undergoing Cardiopulmonary Bypass-Supported Cardiac Surgery.

Authors:  Jennifer Bezaire; Dorothy Thomson; Erick McNair
Journal:  J Extra Corpor Technol       Date:  2018-09

6.  A novel mutation (4040-4045 nt. delA) in exon 14 of the factor VIII gene causing severe hemophilia A.

Authors:  Habib Onsori; Mohammad Ali Hosseinpour Feizi; Abbas Ali Hosseinpour Feizi
Journal:  Indian J Hum Genet       Date:  2011-09

7.  A Novel Missense Mutation, E1623G, in the Human Factor VIII Gene Associated With Moderate Haemophilia A.

Authors:  Habib Onsori; Mohammad Ali Hosseinpour Feizi; Abbas Ali Hosseinpour Feizi
Journal:  Iran Red Crescent Med J       Date:  2014-01-05       Impact factor: 0.611

8.  Cardiovascular and haematological events post COVID-19 vaccination: A systematic review.

Authors:  Dana Al-Ali; Abdallah Elshafeey; Malik Mushannen; Hussam Kawas; Ameena Shafiq; Narjis Mhaimeed; Omar Mhaimeed; Nada Mhaimeed; Rached Zeghlache; Mohammad Salameh; Pradipta Paul; Moayad Homssi; Ibrahim Mohammed; Adeeb Narangoli; Lina Yagan; Bushra Khanjar; Sa'ad Laws; Mohamed B Elshazly; Dalia Zakaria
Journal:  J Cell Mol Med       Date:  2021-12-29       Impact factor: 5.310

9.  A proteome-wide genetic investigation identifies several SARS-CoV-2-exploited host targets of clinical relevance.

Authors:  Maya Ghoussaini; Ian Dunham; Mohd Anisul; Jarrod Shilts; Jeremy Schwartzentruber; James Hayhurst; Annalisa Buniello; Elmutaz Shaikho Elhaj Mohammed; Jie Zheng; Michael Holmes; David Ochoa; Miguel Carmona; Joseph Maranville; Tom R Gaunt; Valur Emilsson; Vilmundur Gudnason; Ellen M McDonagh; Gavin J Wright
Journal:  Elife       Date:  2021-08-17       Impact factor: 8.140

10.  Evaluation of transfusion-related complications along with estimation of inhibitors in patients with hemophilia: A pilot study from a single center.

Authors:  Anju Dubey; Anupam Verma; Priti Elhence; Prashant Agarwal
Journal:  Asian J Transfus Sci       Date:  2013-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.